In today’s fast-changing world, data has become increasingly important in all aspects of life, especially in drug and vaccine development. The use of big data in pharmacogenomics and non-clinical trials has revolutionized drug development, providing vast amounts of new information on the genomes of many individual NHPs and gene expression patterns and allowing researchers to analyze large amounts of genetic data quickly and accurately. In addition, collecting genetic primate data also help researchers to optimize the use of this animal model to study complex human diseases because some researchers use extended rhesus pedigrees, coupled with next-generation sequencing. Thus, processing programs of generic data and managing data processing software will be necessary for future drug and vaccine development.

In conclusion, genetic data in primates play a critical role in drug and vaccine development. Researchers can gain valuable insights into the efficacy and safety of new drugs and vaccines by using primates as models for human disease. Moreover, using big data in pharmacogenomics and non-clinical trials has transformed the drug development process, providing researchers with powerful tools to optimize the use of this animal model and analyze genetic data quickly and accurately. As the world continues to embrace data-driven approaches, genetic data in primates will remain indispensable tools for drug and vaccine development.